Skye Bioscience Inc (SKYE)

HEALTH CARE: PHARMACEUTICALS
SIC: METAL MINING

297 PRESIDENT STREET BROOKLYN, NY 11231

Nemus Bioscience, Inc. is a biopharmaceutical company. The Company develops and distributes products that are designed to alleviate a variety of diseases by targetting the nervous and immune systems. Nemus Bioscience offers its products to the healthcare industry around the world.

Data as of 2021-05-08 11:37:55 -0400
Market Cap33.455 Million Shares Outstanding371.724 Million Avg 30-day Volume1.568 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low0.246 / 0.0245 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from SKYE instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 1 2 -50.0% 1 (0.06%) 1 (0.06%) 0.0%
13F shares: 14.48 Million 14.95 Million -3.14% 14.48 Million 14.937 Million -3.06%
% Ownership 5.7903 5.9781 -3.14% 5.7903 5.9729 -3.06%
New Positions: 2 1
Increased Positions
Closed Positions 1 1 0.0%
Reduced Positions 1 1
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SKYE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SKYE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

JANNEY RICHARD PRINCIPAL ACCOUNTING OFFICER

0 2020-09-25 1

HEPPELL JAMES L

500,000 2020-08-07 1

DHILLON PUNIT CEO

1,000,000 2020-08-07 1

EMERALD HEALTH SCIENCES INC.

123,923,501 2020-08-07 2

KIM DENNIS D CHIEF MEDICAL OFFICER

0 2020-08-07 1

TRAISTARU ELENA CFO AND SECRETARY

0 2020-08-07 1

DALESANDRO MARGARET

  • Director
0 2020-08-07 2

DHILLON AVTAR S

  • Director
0 2018-10-10 0

CESARIO DOUGLAS A CFO AND SECRETARY

  • Officer
643,501 2018-07-23 0

BERECZ ELIZABETH CHIEF FINANCIAL OFFICER

1,050,000 2018-01-18 0

LYKOS COSMAS N CHAIRMAN

4,599,400 2018-01-18 0

MURPHY BRIAN STUART CEO, CHIEF MEDICAL OFFICER

1,275,000 2018-01-18 0

LAPHAM REG ALEXANDER

  • 10% Owner
3,787,500 2017-03-13 0

MCLAUGHLIN GERALD W.

  • Director
61,250 2015-10-20 0

GEORGE THOMAS

  • Director
60,000 2015-10-20 0

INGRAM DOUGLAS S VICE CHAIRMAN

  • Officer
  • Director
372,500 2015-10-20 0

LADIN BRIAN D

  • 10% Owner
249,098 2015-04-08 0

SQUIRES RICHARD D.

  • 10% Owner
1,500,000 2015-04-03 0

HOLLISTER JOHN B CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2014-12-04 0

MENDEZ FRANCISCO JAVIER

  • FORMER OFFICER AND DIRECTOR
No longer subject to file 2014-10-31 0

MENDEZ YOSBANI

  • FORMER OFFICER, DIRECTOR, 10%
No longer subject to file 2014-10-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SKYE BIOSCIENCE INC SKYE 2021-05-14 22:15:03 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 21:45:03 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 21:15:03 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 20:45:03 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 20:15:04 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 19:45:02 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 19:15:03 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 18:45:03 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 18:15:03 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 17:45:03 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 17:15:03 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 16:45:03 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 16:15:03 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 15:45:03 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 15:15:02 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 14:45:04 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 14:15:03 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 13:45:03 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 13:15:03 UTC -0.8295 0.8795 2100000
SKYE BIOSCIENCE INC SKYE 2021-05-14 12:45:03 UTC -0.8295 0.8795 1600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments